Nu Skin Enterprises (NYSE:NUS) Updates FY 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 0.900-1.300 for the period, compared to the consensus estimate of 0.760. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.7 billion. Nu Skin Enterprises also updated its Q1 2025 guidance to 0.100-0.200 EPS.

Nu Skin Enterprises Trading Up 1.3 %

Shares of Nu Skin Enterprises stock traded up $0.09 during trading hours on Thursday, reaching $6.41. The stock had a trading volume of 1,274,980 shares, compared to its average volume of 687,085. The firm has a market capitalization of $318.40 million, a price-to-earnings ratio of -3.09 and a beta of 1.17. Nu Skin Enterprises has a 1 year low of $5.95 and a 1 year high of $17.68. The company has a current ratio of 1.93, a quick ratio of 1.20 and a debt-to-equity ratio of 0.53. The firm has a 50 day simple moving average of $6.91 and a two-hundred day simple moving average of $7.50.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 5.81% and a positive return on equity of 5.47%. As a group, equities research analysts anticipate that Nu Skin Enterprises will post 0.68 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have recently issued reports on NUS. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Monday, November 11th. DA Davidson decreased their price target on Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating for the company in a report on Friday, December 20th. Finally, Citigroup dropped their price objective on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research note on Tuesday, October 22nd.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.